Cranbury, NJ, April 21,2021. J-STAR Research, a leading provider of services in complex organic synthesis and crystallization for a variety of pharmaceutical clients globally, is launching its 2nd annual Pharmaceutical Crystallization Summit through its CfPC (Center for Pharma Crystallization) with …
CfPC is pleased to announce our collaboration in the 2nd Edition of Fundamental of Solid Formulation (FSF2021) webinar series, featuring an impressive line-up of speakers and topics.
This is a 7-week webinar series with a webinar every Wednesday from April …
Porton Pharma Solutions Ltd. celebrates its 15th Anniversary…
Cranbury, N.J., June 26, 2020 – J-STAR Research, a leading provider of services in complex organic synthesis and crystallization for a variety of pharmaceutical clients globally, today launched its 1st annual Pharmaceutical Crystallization Summit, organized by CfPC (Center …
Crystallization technologies are bridges between drug substances and drug products enabling consistent safety and efficacy profiles of small molecule based medicines. To fully utilize existing tools and develop better new methodologies for solving bottleneck problems in new drug development, the …
We are pleased to announce a 7-week #webinar series on #solid #formulations, organized by XtalPi Inc. and J-STAR Research, Inc. Leading experts will present insights into R&D workflows, strategies, and best practices to implement new technologies for #solidform design …
J-STAR Research has recently established significant impurity isolation and structural elucidation capabilities. The R&D team is comprised of experts in identifying and characterizing low levels (e.g. 0.1%) of impurities in chemical intermediates and APIs. This is done by impurity enrichment …
South Plainfield, NJ., March 12, 2020 — J-STAR Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://www.jstar-research.com. The new site …
March 10, 2020, Chongqing • China–XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement today. The two parties aim to carry out all-round strategic cooperation on the …
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary of Porton, has closed the …
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ — Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L.L.C. (“PTC”), a wholly-owned subsidiary …
